Delivery Order SPE2DR25D2104-SPE2DR26F3NSN
- Not listed
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $5,524.91 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on June 25, 2025, with completion targeted for June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,768.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 10-320 mg on July 14, 2025, with completion expected by July 15, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,699.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This non-set-aside, competitively awarded delivery order is scheduled for completion by November 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) with a ceiling value of $1,117.93. This firm fixed price delivery order, awarded on May 15, 2025, represents a non-set-aside competitive award with an ultimate completion date of May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,701.12 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 5-160-12.5 mg tablets (30-count package), a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on September 22, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.24 to AmerisourceBergen Drug Corp for Exforge HCT 10-160-12.5 mg tablets (30-count supply) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,007.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Exforge 5-320 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count) under a firm fixed-price contract with a ceiling value of $3,399.87. This non-set-aside award, issued on June 25, 2025, with an ultimate completion date of June 26, 2025, represents a single delivery order for this antihypertensive medication to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NSNDelivery Order
The Defense Logistics Agency awarded a $1,781.17 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Exforge 5-160 mg, a combination antihypertensive medication. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by November 12, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that supports military healthcare systems globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare programs. The company maintains an extensive portfolio of federal contract awards covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order reflects the company's ongoing role as a primary supplier of pharmaceutical products to support military medical operations and readiness initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/10/25 |